Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Michael M. Rowe | Chief Executive Officer | 2024-08-28 | 27,071 | $0.52 | $14.08kBuy |
Michael M. Rowe | Chief Executive Officer | 2024-08-26 | 50,000 | $0.57 | $28.50kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Stuart M. Grant | 191.66% | 10,914,153 | $67.78M | Insider |
Shuhei Yoshida | 30.76% | 1,751,900 | $10.88M | Insider |
Senju Pharmaceutical Co Ltd | 30.18% | 1,718,566 | $10.67M | Insider |
Fredric N. Eshelman | 28.43% | 1,618,835 | $10.05M | Insider |
Hyunsu Jung | 26.34% | 1,500,000 | $9.32M | Insider |
Curt H. Labelle | 11.39% | 648,903 | $4.03M | Insider |
Ernest Mario | 6.72% | 382,706 | $2.38M | Insider |
Jennifer G. Clasby | 1.17% | 66,537 | $413.19k | Insider |
Kenneth B. Lee Jr. | 1.13% | 64,544 | $400.82k | Insider |
Avenue Capital Management II LP | 1.08% | 61,238 | $380.29k | Insider |